期刊文献+

小剂量普奈洛尔预防肝硬化食管胃底静脉曲张破裂出血的疗效研究 被引量:2

The efficacy of low dose propranolol for prevention of esophageal variceal bleeding
暂未订购
导出
摘要 目的探讨小剂量心得安预防食管静脉曲张再出血的疗效。方法对50例治疗组患者和50例对照组患者进行前瞻性对照研究,在用药前后用彩色多普勒超声仪检测其门静脉系统血流动力学的变化,并动态监测患者的基础心率及EVB复发情况。结果用药1个月后治疗组门静脉内径、基础心率显著下降,分别下降为(1.30±0.22)cm、(57.0±4.2)次/min,与用药前比较有显著差异。随访1年,实验组再出血率明显少于对照组。结论小剂量心得安预防EVB复发是安全有效的,值得在临床进一步研究和试用。 Objective To assess the efficacy of low dose propranolol in the prevention of esophageal variceal bleeding. Methods A prospective controlled study was conducted in the treated group(50 cases), and the control group(50 cases), by detecting the portal system hemodynamics in patients with portal hypertension and esophageal varices used color Doppler ultrasound technique. Meanwhile the heart rate and partal vein diameter were observed. Results After 1 months administration of the drugs, the heart rate and the diameter of partal vein ewre significantly decreased with the values of(1.30±0.22) cm and(57.0±4.2) bpm, respectively. In the follow-up period of 1 year, the rebleeding rate of the treated group was less than the control group. Conclusion Low dose propranolol is a effective therapy in preventing recurrent esophageal variceal bleeding, and worth further study.
出处 《中国现代医生》 2014年第7期153-155,共3页 China Modern Doctor
关键词 肝硬化食管胃底静脉曲张破裂出血 心得安 疗效研究 Esophageal variceal bleeding Propranolol Effect study
  • 相关文献

参考文献15

  • 1Fullwood D. Portal hypertension and varices in patients with liver cirrhosis[J]. Nurs Stand,2012,26(48) :52-57.
  • 2Chen YI,Ghali P. Prevention and management of gastroe- sophageal varices in cirrhosis[J]. Int J Hepatol,2012, 2012: 750150.
  • 3Augustin S, Millan L, Gonzalez A, et al. Prognostic evalu- ation of patients with acute variceal bleeding[J]. Dis Mark- ers,2011,31 (3) : 155-164.
  • 4Thiele M, Krag A, Rohde U, et al. Meta-analysis : banding ligation and medical interventions for the prevention of re- bleeding from oesophageal varices[J]. Aliment Pharmacol Ther,2012,35 (10) : 1155-1165.
  • 5Bernard B,Lebrec D,Mathurinp,et al. Beta -adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis:a meta-analysis[J]. Hepatology, 1997,25 ( 1 ) : 63-70.
  • 6陈灏珠 朱禧星 沈稚舟.实用内科学[M]第11版[M].北京:人民卫生出版社,2004.1151.
  • 7Farias AQ, Kassab F,da Rocha EC,et al. Propranolol re- duces variceal pressure and wall tension in schistosomia- sis presinusoidal portal hypertension[J]. J Gastroenterol Hepatol. 2009,24 (12) : 1852-1856.
  • 8魏倪,杨方,刘丹阳.慢性乙型肝炎临床和肝组织学诊断的对比分析[J].中华肝脏病杂志,2010,18(9):709-710. 被引量:6
  • 9陆星华,张泰昌.食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年)[J].中华消化内镜杂志,2004,21(3):149-151. 被引量:435
  • 10Augustin S, Altamirano J, Gonz41ez A, et al. Effectiveness of combined pharmacologic and ligation therapy in high- risk patients with acuteesophageal variceal bleeding[J]. Am J Gastroenterol, 2011,106(10) : 1787-1795.

二级参考文献16

共引文献617

同被引文献28

  • 1李兴华.门脉高压性胃病的进展[J].胃肠病学和肝病学杂志,2007,16(1):19-21. 被引量:6
  • 2陈灏珠.实用内科学[M].11版.北京:人民卫生出版社,2004.1857-1859.
  • 3Groszmann R J,Garcia Tsao G,Bosch J ,et al. Beta blockers to prevent gastroesophageal varices in patients with cirrhosis[J]. N Engl J Med,2005,353(21) :2254-2261.
  • 4Blei A T. Portal hypertension and its complications[J]. Curr Opin Gastroenterol,2007,23(3) :275 280.
  • 5de Franchis R. Evolving consensus in portal hypertension. Re port of the Baveno IV consensus workshop on methodology oi diagnosis and therapy in portal hypertension[J]. J Hepatol, 2005,43(1) :167-176.
  • 6Reiberger T,Ulbrich G,Ferlitsch A,et al, Carvedilol for prima- ry prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol[J]. Gut, 2013, 62 (11) :1634-1641.
  • 7La Mura V,Abraldes J G,Raffa S,et al. Prognostic value of a cute hemodynamic response to i. v. propranolol in patients with cirrhosis and portal hypertension[J]. J Hepatol,2009,51(2): 279 287.
  • 8Banares R, Moitinho E, Matilla A, et al. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis[J]. Hepatology, 2002,36(6) : 1367-1373.
  • 9Patchett S E, Enright H, Afdhal N, et al. Clot lysis by gastric juice:an in vitro study[J]. Gut, 1989,30(12) : 1704-1707.
  • 10Yacyshyn B R,Thomson A B. The clinical importance of pro ton pump inhibitor pharmacokinetics [J ]. Digestion, 2002, 66 (2).-67 68.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部